| 标题 |
Phase II study of maintenance niraparib rechallenge plus bevacizumab in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a poly (ADP-ribose) polymerase inhibitor (KGOG-3056/NIRVANA-R) |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)